Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?

Physicians and patients have long been aware of skin lesions at the sites of insulin injections, referred to as lipodystrophy that can present as lipoatrophy (LA) or lipohypertrophy (LH). However, the reported prevalence of these different skin lesions varies widely, emphasizing the need for a corre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Sandro, Strollo, Felice, Ceriello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014793/
https://www.ncbi.nlm.nih.gov/pubmed/27456528
http://dx.doi.org/10.1007/s13300-016-0187-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014793/
https://www.ncbi.nlm.nih.gov/pubmed/27456528
http://dx.doi.org/10.1007/s13300-016-0187-6

Ejemplares similares